10:10am ET
Health and Healthcare
Major Biotechs See Rising Tide in Short Interest
The November 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Companies
/Healthcare
Gilead Sciences Inc
$146.64
▼ $4.36 (−2.88%) today
Markets closed · 3:56am ET
GILD Coverage
Page 209:50am ET
Health and Healthcare
4 Large Cap Biotech Leaders Are Huge Tax Reform Winners
One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for the large cap leaders in the group.
10:05am ET
Health and Healthcare
2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Amazon, Barrick Gold, Boston Scientific, Chipotle, Gap, Gilead, Goldcorp, Workday and More
The top analyst upgrades, downgrades and other research calls from Thursday include Amazon, Barrick Gold, Boston Scientific, Chipotle Mexican Grill, Gap, Gilead Sciences, Goldcorp and Workday.
1:30pm ET
Health and Healthcare
Why Argus Is Taking a Step Back on Gilead Sciences
Gilead Sciences, Inc. (NASDAQ: GILD) saw its shares take a step back on Monday after an independent research firm downgraded the stock. Many investors have been hoping that the shares will pull…
Chris Lange 9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Best Buy, Equifax, Gilead, MongoDB, NVIDIA, Rio Tinto, Teva, UPS and More
The top analyst upgrades, downgrades and other research calls from Monday include Best Buy, Equifax, Gilead Sciences, MongoDB, NVIDIA, Rio Tinto, Teva Pharmaceutical and UPS.
10:40am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
8:40am ET
Health and Healthcare
Despite Poor Earnings Reaction, Analysts Still See Upside for Gilead
Out of all the biotechs that reported earnings last week, Gilead Sciences seems to be the one that hasn’t been taking its medicine in 2017.
Chris Lange 4:18pm ET
Health and Healthcare
Gilead Earnings Bring Mixed Results
Gilead Corporation (NASDAQ: GILD) has joined other biotech giants in releasing its earnings for the third quarter of 2017. The company’s market cap was last seen at $101 billion before earnings, and…
Jon C. Ogg 10:40am ET
Health and Healthcare
Short Sellers Chase Biotechs Higher
The October 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
10:45am ET
Health and Healthcare
Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week
At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.
12:15pm ET
Health and Healthcare
Does Gilead’s CAR T Approval Vindicate the High Acquisition Price for Kite Pharma?
Now there is a new FDA approval Gilead's CAR T lymphoma treatment named Yescarta that has created at least some buzz for Gilead.
Jon C. Ogg 2:05pm ET
Health and Healthcare
Are Analysts Secretly Calling Gilead a Screaming Buy?
Sometimes it turns out that great growth companies eventually run into the day when getting the growth of the past is not possible. That has been the case of Gilead Sciences since…
Jon C. Ogg 11:35am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More
The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Gilead, Johnson & Johnson, Potash, Schlumberger, Visa and Walmart.